Novavax soars 146% on $1.2 billion Sanofi vaccine licensing deal
Novavax Inc. shares surged after the corporate signed a $1.2 billion licensing settlement with Sanofi that features commercializing a mixed...
licensing
Novavax Inc. shares surged after the corporate signed a $1.2 billion licensing settlement with Sanofi that features commercializing a mixed...
